A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic / Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic / Pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients With Acute Ischemic Stroke.

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2009

At a glance

  • Drugs Repinotan (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2009 Results reported in Stroke.
    • 01 Nov 2009 Primary endpoint 'Barthel Index' has not been met.
    • 20 May 2009 Additional locations and actual patient number as 782 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top